Why Shares of Twist Bioscience Fell 19.92% on Tuesday
A day after synthetic biology and genomics company Twist Bioscience (NASDAQ: TWST) saw its shares rise 16.1%, they did a U-turn, falling 19.92% on Tuesday. A report issued Tuesday by Scorpion Capital sent Twist's shares plummeting. In its third-quarter report, released Aug. 5, Twist said it had $56.1 million in revenue, up 60.2%, year over year and 37.4% sequentially.